P L Nara

Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles.

G. Learn, A. Rodrigo, J. Mullins, 1998, Virology.

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.

D R Burton, R. M. Hendry, J. Pyati, 1994, Science.

In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity.

D R Burton, R. M. Hendry, C. Barbas, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.

H. Kung, P. Nara, P L Nara, 1996, Virology.

Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies

J. Goudsmit, M. Schutten, M Schutten, 1993, Journal of virology.

Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.

C. Barbas, F. Chiodi, E. Norrby, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

L K Pannell, L. Pannell, K. Gustafson, 1997, Antimicrobial agents and chemotherapy.